MIRABELLA FINANCIAL SERVICES LLP
Position in CRNX — Crinetics Pharmaceuticals, Inc.
CIK 1538853
London, X0
Position in CRNX
as of Jun 30, 2026
· filed Jul 31, 2026
Position Value
$328,023
New position
Shares Held
8,766
first reported quarter
Ownership
0.008%
of shares outstanding
% of Portfolio
0.04%
of 13F equity value
Holder Rank
#171
of 266 holders
Holding Since
Jun 2026
1 quarter on record
Voting authority
Sole 80%
Shared 0%
None 20%
Position in Biotechnology
Healthcare · as of Jun 30, 2026MIRABELLA FINANCIAL SERVICES LLP holds $3,358,382 across 9 Biotechnology names. CRNX ranks #4 (9.8% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | HRMY |
Harmony Biosciences Holdings, Inc.
|
31,014 | $1,129,219 | |
| 2 | OCUL |
Ocular Therapeutix, Inc
|
44,619 | $438,158 | |
| 3 | AXSM |
Axsome Therapeutics, Inc.
|
1,367 | $334,600 | |
| 4 | CRNX |
Crinetics Pharmaceuticals, Inc.
This page
|
8,766 | $328,023 | |
| 5 | ABVX |
Abivax S.A.
|
2,337 | $311,428 | |
| 6 | CORT |
Corcept Therapeutics Inc
|
3,009 | $261,632 | |
| 7 | INVA |
Innoviva, Inc.
|
10,744 | $243,996 | |
| 8 | NUVB |
Nuvation Bio Inc.
|
30,093 | $170,928 |
All Filings in CRNX
Export CSV
1 filing row on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $328,023 | 8,766 | Shares | Sole | 2026-07-31 | |
| No filing history on record for this holder in this stock. | ||||||